A new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by a smartphone. (Image: Laboratory of Nanostructures and Biosensing, University of Minnesota)

A research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by a smartphone. The University of Minnesota — Twin Cities innovation opens the door for faster and more affordable at-home medical testing.

Microfluidics involves the study and manipulation of liquids at a very small scale. One of the most popular applications in the field is developing “lab-on-a-chip” technology, or the ability to create devices that can diagnose diseases from a very small biological sample, blood, or urine, for example.

Scientists already have portable devices for diagnosing some conditions — rapid COVID-19 antigen tests, for one. However, a big roadblock to engineering more sophisticated diagnostic chips that could, for example, identify the specific strain of COVID-19 or measure biomarkers like glucose or cholesterol, is the fact that they need so many moving parts. Chips like these would require materials to seal the liquid inside, pumps and tubing to manipulate the liquid, and wires to activate those pumps — all materials that are difficult to scale down to the micro level. Researchers at the University of Minnesota Twin Cities were able to create a microfluidic device that functions without all of those bulky components.

The U of M team’s microfluidic device functions without all of the bulky components typically required for complex lab-on-a-chip diagnostic technology. (Image: Laboratory of Nanostructures and Biosensing, University of Minnesota)

“Researchers have been extremely successful when it comes to electronic device scaling, but the ability to handle liquid samples has not kept up,” said Sang-Hyun Oh, a professor in the University of Minnesota Twin Cities department of electrical and computer engineering and senior author of the study. “It’s not an exaggeration that a state-of-the-art, microfluidic lab-on-a-chip system is very labor intensive to put together. Our thought was, can we just get rid of the cover material, wires, and pumps altogether and make it simple?”

Many lab-on-a-chip technologies work by moving liquid droplets across a microchip to detect the virus pathogens or bacteria inside the sample. The University of Minnesota researchers’ solution was inspired by a peculiar real-world phenomenon with which wine drinkers will be familiar — the “legs,” or long droplets that form inside a wine bottle due to surface tension caused by the evaporation of alcohol.

Using a technique pioneered by Oh’s lab in the early 2010s, the researchers placed tiny electrodes very close together on a 2 × 2 cm chip, which generate strong electric fields that pull droplets across the chip and create a similar “leg” of liquid to detect the molecules within.

Because the electrodes are placed so closely together (with only 10 nm of space between), the resulting electric field is so strong that the chip only needs less than a volt of electricity to function. This incredibly low voltage required allowed the researchers to activate the diagnostic chip using near-field communication signals from a smartphone, the same technology used for contactless payment in stores.

This is the first time researchers have been able to use a smartphone to wire lessly activate narrow channels without microfluidic structures, paving the way for cheaper, more accessible at-home diagnostic devices.

“This is a very exciting, new concept,” said Christopher Ertsgaard, lead author of the study and a recent CSE alumnus (ECE PhD ’20). “During this pandemic, I think everyone has realized the importance of at-home, rapid, point-of-care diagnostics. And there are technologies available, but we need faster and more sensitive techniques.”

Oh’s lab is working with Minnesota startup company GRIP Molecular Technologies, which manufactures at-home diagnostic devices, to commercialize the microchip platform. The chip is designed to have broad applications for detecting viruses, pathogens, bacteria, and other biomarkers in liquid samples.

“To be commercially successful, in-home diagnostics must be low cost and easy to use,” said Bruce Batten, Founder and President of GRIP Molecular Technologies. “Low voltage fluid movement, such as what Professor Oh’s team has achieved, enables us to meet both of those requirements.”

For more information, contact Rhonda Zurn at This email address is being protected from spambots. You need JavaScript enabled to view it..



Magazine cover
Tech Briefs Magazine

This article first appeared in the October, 2022 issue of Tech Briefs Magazine.

Read more articles from this issue here.

Read more articles from the archives here.